Open AccessRadiopharmaceutical Supply Disruptions and the Use of 99mTc-Hydroxymethylene Diphosphonate as an Alternative to 99mTc-Pyrophosphate for the Diagnosis of Transthyretin Cardiac Amyloidosis: An ASNC Information Statement
Author(s) -
Edward J. Miller,
Andrew J. Einstein,
Roxana Campisi,
Nishant R. Shah,
Sean R. McMahon,
Sarah Cuddy,
Cesia Gallegos-Kattán,
Mathew S. Maurer,
Thibaud Damy,
Riemer H. J. A. Slart,
Ketan Bhatia
Publication year - 2022
Publication title -
zenodo (cern european organization for nuclear research)
Language(s) - English
DOI - 10.5281/zenodo.6722118
Subject(s) - transthyretin , cardiac amyloidosis , medicine , statement (logic) , amyloidosis , pyrophosphate , chemistry , philosophy , epistemology , biochemistry , enzyme